Hims & Hers Health HIMS Return on equity
Return on equity at other companies
Other financials
Where this comes from
Calculated from Hims & Hers Health’s reported figures.
Based on trailing twelve months.
The official record: Hims & Hers Health’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Hims & Hers Health's return on equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Hims & Hers Health's return on equity?
- Hims & Hers Health (HIMS) reported return on equity of -2.7% in Q1 2026.
- How has Hims & Hers Health's return on equity changed year-over-year?
- Hims & Hers Health's return on equity decreased by 107.2% year-over-year, from 36.8% to -2.7%.
- What is the long-term trend for Hims & Hers Health's return on equity?
- Over 3 years (2022 to 2025), Hims & Hers Health's return on equity has grown at a 7.5% compound annual growth rate (CAGR), from -20.3% to 25.2%.
- What does return on equity mean?
- How much profit the company earns on the money shareholders have invested.
- How do you interpret return on equity?
- Higher is better, but very high ROE can be manufactured by leverage — a thin equity base inflates the ratio. Read it next to debt-to-equity and ROIC to tell genuine returns from balance-sheet engineering.
- How does return on equity compare across companies?
- Comparable across peers, with the leverage caveat. Negative or near-zero equity makes ROE meaningless, so it is suppressed there.